Rebecca Spencer

5PUBLICATIONS
9CO-AUTHORS
Infant and child healthGene and molecular therapyPharmaceutical delivery technologiesPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 14, 2025
Placental Protein Citrullination Signatures Are Modified in Early- and Late-Onset Fetal Growth Restriction.

Owen R Vaughan, Kasia Maksym, Sara Hillman

|Feb 28, 2023
Response to Moldenhauer, Johnson & Van Mieghem ISPD 2022 DEBATE: There should be formal accreditation and ongoing quality assurance/review for units offering fetal therapy that includes public reporting of outcomes. MFAET, an international standardised medical terminology to support quality assurance/review for units offering fetal therapy.

Anna L David, Rebecca N Spencer

|Jul 26, 2022
Improving Development of Drug Treatments for Pregnant Women and the Fetus.

Anna L David, Homa Ahmadzia, Richard Ashcroft

|May 02, 2019
Pregnant women's experiences and perceptions of participating in the EVERREST prospective study; a qualitative study.

Merryl E Harvey, Anna L David, Jade Dyer

|Jan 25, 2017
EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction.

Rebecca Spencer, Gareth Ambler, Jana Brodszki

Pageof 1

Frequent Collaborators

3 joint publications

Anna L David

1 joint publications

Homa Ahmadzia

1 joint publications

Richard Ashcroft

1 joint publications

Christina Bucci-Rechtweg